EXOZ (Invizyne Technologies) Net Profit

Corporate emblem and logo of invizyne.com (EXOZ)

eXoZymes Inc (EXOZ) specializes in the development and commercialization of complex chemical compounds. However, military conflicts and geopolitical instability are triggering a sharp rise in raw material prices and disrupting supply chains for enzyme components. This market trend, visualized in monetary terms, demonstrates profit at the level of -0.01. To ensure stability, the business is expanding its supplier pool and building strategic product reserves in warehouses.

EXOZ (eXoZymes) Company Net Income history from 02/13/2025 to 10/30/2026
Flagship merchandise of Invizyne Technologies

For eXoZymes Inc (EXOZ), the company's current net result reflects a critical transition from laboratory development to industrial scaling. This metric captures the actual volume of funds remaining after covering all operating expenses amidst competitive conditions. The trend is formed by aggregating daily market equilibrium points, eliminating quarterly reporting gaps. It is vital for investors to monitor the company's progress in overcoming its dependence on external financing. Steady growth of the line would confirm the achievement of a safe profit margin.

Main competitors

Net Income Haleon Corp|KVUE (Kenvue Inc.) - Net Profit|Net Profit veronapharma.com|Net Income MENS (Jyong Biotech)|LGND (Ligand Pharmaceuticals Incorporated) - Final Profit|Company Net Income Amneal Pharmaceuticals Inc AMRX|Perrigo Corp (PRGO) - Company Net Income|ALVO: Net Income|liquidia.com - Profit After Payment of Taxes|GLPG: Net Profit|ANI Pharmaceuticals Inc - Final Profit|MNKD (MannKind Corp.) - Net Profit|Company Net Income Amphastar Corp AMPH|Company Net Income Pacira BioSciences (PCRX)|SPRY (ars-pharma.com) - Final Profit|Net Profit TBPH (Theravance Biopharma, Inc.)|Aquestive Therapeutics Inc (AQST) - Company Net Income|SCPH: Net Income|TECX (Tectonic Therapeutic, Inc.) - Company Profit|Tonix Pharmaceuticals (TNXP) - Company Net Income|Company Net Income China SXT Pharmaceuticals, Inc. (SXTC)|Net Income EPRX|BioHarvest Sciences, Inc. - Profit After Tax|Net Income ORMP (Oramed Pharmaceuticals)|ENTX - Company Net Income|Company Net Income MindWalk Holdings HYFT|ABVC - Net Income|Cumberland Pharmaceuticals Inc. - Net Profit|Company Net Income Quantum BioPharma Ltd.|FibroGen Corp (FGEN) - Company Net Income|TELO - Net Financial Result|Net Income RANI|SNYR: Final Profit|Net Profit RLYB|Net Financial Result lexariabioscience.com|Company Net Income Pulmatrix Corp PULM|PTHL: Company Profit|Aptorum - Net Profit|lyratherapeutics.com (LYRA) - Net Income|IBO: Net Profit|Company Net Income TNF Pharmaceuticals, Inc. (TNFA)|Net Income YCBD|Company Profit PRFX (PainReform Corp)|Company Net Income Altamira Therapeutics (CYTO)|LIPO - Company Net Income|OptiNose - Net Income|PIRS (Pieris Pharmaceuticals Inc) - Profit After Tax|PROC - Company Net Income|Profit After Tax PTPI|QLI: Net Profit|acelyrin.com - Final Profit|TFFP (TFF Pharmaceuticals, Inc.) - Net Profit